Wed, August 10, 2022

Tejas Savant Maintained (SOPH) at Buy with Decreased Target to $13 on, Aug 10th, 2022

Tejas Savant of Morgan Stanley, Maintained "SOPHiA GENETICS SA" (SOPH) at Buy with Decreased Target from $14 to $13 on, Aug 10th, 2022.

Tejas, nor any peers, have made any analyst calls on SOPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30